611 - 620 of 6284 Results
Title
Year
- Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease2023OPENTitle: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18443End Page: e18443Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443Best OA location URL: https://doi.org/10.1016/j.heliyon.2023.e18443Citation Count: 2
- Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study2023OPENTitle: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up studyJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18538End Page: e18538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538Best OA location URL: http://www.cell.com/article/S2405844023057468/pdfCitation Count: 0
-
OPENTitle: Age and sex differentially shape brain networks in Parkinson's diseaseJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 29Issue #: 7Start Page: 1907End Page: 1922Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.14149Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.14149Citation Count: 31
-
OPENTitle: The effects of AQP4 rs162009 on resting‐state brain activity in Parkinson's diseaseJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 29Issue #: 9Start Page: 2645End Page: 2655Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.14208Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.14208Citation Count: 13
- Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms2023OPENTitle: Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptomsJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 29Issue #: 8Start Page: 2259End Page: 2266Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.14173Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.14173Citation Count: 11
- Association of coffee consumption and striatal volume in patients with Parkinson's disease and healthy controls2023OPENTitle: Association of coffee consumption and striatal volume in patients with Parkinson's disease and healthy controlsJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 29Issue #: 10Start Page: 2800End Page: 2810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.14216Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.14216Citation Count: 5
- Fast decoding cell type–specific transcription factor binding landscape at single-nucleotide resolution2021OPENTitle: Fast decoding cell type–specific transcription factor binding landscape at single-nucleotide resolutionJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 31Issue #: 4Start Page: 721End Page: 731Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.269613.120Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8015851Citation Count: 26
-
OPENTitle: PINK1: From Parkinson’s disease to mitophagy and back againJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 21Issue #: 6Start Page: e3002196End Page: e3002196Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3002196Best OA location URL: https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3002196&type=printableCitation Count: 11
-
OPENTitle: Genome-wide Analysis of Motor Progression in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200092Best OA location URL: https://ng.neurology.org/content/nng/9/5/e200092.full.pdfCitation Count: 5
- Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease2023OPENTitle: Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00374-wBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00374-wCitation Count: 26